tiprankstipranks
Advertisement
Advertisement
Haemonetics: CSL Plasma Migration Deal Highlights Long-Term Upside but Near-Term Risk/Reward Keeps Rating at Hold
PremiumRatingsHaemonetics: CSL Plasma Migration Deal Highlights Long-Term Upside but Near-Term Risk/Reward Keeps Rating at Hold
19d ago
Haemonetics announces  supply agreement with CSL Plasma
Premium
The Fly
Haemonetics announces supply agreement with CSL Plasma
19d ago
Haemonetics up 9% at $98.50 in pre-market on CSL Plasma supply agreement
Premium
The Fly
Haemonetics up 9% at $98.50 in pre-market on CSL Plasma supply agreement
19d ago
Haemonetics price target raised to $105 from $90 at Raymond James
PremiumThe FlyHaemonetics price target raised to $105 from $90 at Raymond James
30d ago
Haemonetics price target raised to $96 from $88 at Baird
Premium
The Fly
Haemonetics price target raised to $96 from $88 at Baird
30d ago
Haemonetics price target raised to $95 from $89 at Barrington
Premium
The Fly
Haemonetics price target raised to $95 from $89 at Barrington
30d ago
Haemonetics’ Vascade MVP system shows efficacy in electrophysiology study
PremiumThe FlyHaemonetics’ Vascade MVP system shows efficacy in electrophysiology study
1M ago
Haemonetics price target raised to $93 from $80 at BofA
Premium
The Fly
Haemonetics price target raised to $93 from $80 at BofA
1M ago
Haemonetics Adds Veteran Director as Shareholders Back Governance
Premium
Company Announcements
Haemonetics Adds Veteran Director as Shareholders Back Governance
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100